Future developments in the prevention, diagnosis and treatment of COVID-19
- PMID: 34016525
- PMCID: PMC8003455
- DOI: 10.1016/j.bpobgyn.2021.03.012
Future developments in the prevention, diagnosis and treatment of COVID-19
Abstract
The impact of the coronavirus disease-2019 (COVID-19) pandemic has been profound and global. Mitigating future waves and overcoming the pandemic is a global public health priority. This review focuses on future developments in the prevention, diagnosis and treatment of COVID-19, which may help to address these challenges. The specific relevance to women's and maternal health, which address the vulnerabilities in this group, is considered. The remarkable scientific achievements that have been made with respect to the development and implementation of both vaccines and therapeutics for COVID-19 are highlighted. The speed and processes for the development, approval and implementation of interventions herald a new way forward in combating emerging infectious diseases. However, it is important to note that this is a rapidly changing field with a constantly evolving knowledge base.
Keywords: COVID-19; Diagnostics; Prevention; SARS-CoV-2; Treatment; Vaccination.
Copyright © 2021. Published by Elsevier Ltd.
Conflict of interest statement
Declaration of competing interest LCF works for the Department of Health and Social Care.
Similar articles
-
Building a Resilient Scientific Network for COVID-19 and Beyond.mBio. 2022 Oct 26;13(5):e0222322. doi: 10.1128/mbio.02223-22. Epub 2022 Sep 20. mBio. 2022. PMID: 36125317 Free PMC article.
-
Clinical development and approval of COVID-19 vaccines.Expert Rev Vaccines. 2022 May;21(5):609-619. doi: 10.1080/14760584.2022.2042257. Epub 2022 Mar 14. Expert Rev Vaccines. 2022. PMID: 35157542 Free PMC article.
-
Behavioral and social science in support of SARS-CoV-2 vaccination: National Institutes of Health initiatives.Transl Behav Med. 2021 Jul 29;11(7):1354-1358. doi: 10.1093/tbm/ibab067. Transl Behav Med. 2021. PMID: 34080616 Free PMC article.
-
COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development.Pharm Nanotechnol. 2020;8(4):323-353. doi: 10.2174/2211738508999200817163335. Pharm Nanotechnol. 2020. PMID: 32811406 Review.
-
COVID-19: Prospective Challenges and Potential Vaccines.Altern Ther Health Med. 2020 Aug;26(S2):72-78. Altern Ther Health Med. 2020. PMID: 32845250 Review.
Cited by
-
Changing Features of Liver Injury in COVID-19 Patients: Impact of Infection with the SARS-CoV-2 Delta (B.1.617.2) Variants.Infect Chemother. 2022 Dec;54(4):744-756. doi: 10.3947/ic.2022.0122. Infect Chemother. 2022. PMID: 36596683 Free PMC article.
-
Exploring primary healthcare practitioners' experiences regarding the coronavirus disease 2019 (COVID-19) pandemic in KwaZulu-Natal, South Africa.Prim Health Care Res Dev. 2022 Nov 4;23:e67. doi: 10.1017/S1463423622000536. Prim Health Care Res Dev. 2022. PMID: 36330843 Free PMC article.
-
Incidence, Causes, and Perinatal Outcomes of "Near-Miss" Obstetric Emergencies during the COVID-19 Pandemic: Experience from a Tertiary Referral Center of Western Rajasthan, India.Indian J Community Med. 2025 Jan-Feb;50(1):76-80. doi: 10.4103/ijcm.ijcm_552_23. Epub 2024 Jun 24. Indian J Community Med. 2025. PMID: 40124816 Free PMC article.
References
-
- BBC News . 2020. Coronavirus: France's first known case 'was in December'.https://www.bbc.co.uk/news/world-europe-52526554
-
- The Guardian . 2020. Could Covid-19 have reached the UK earlier than thought?https://www.theguardian.com/world/2020/jun/01/spate-of-possible-uk-coron...
-
- Live Science . 2020. 1st known case of coronavirus traced back to November in China.https://www.livescience.com/first-case-coronavirus-found.html
-
- WHO . 2020. WHO coronavirus disease (COVID-19) dashboard.https://covid19.who.int/
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous